SCHEMBL6997136

SCHEMBL6997136

CN(C)CCn1c2c(c3ccccc31)C1=C(C(=O)N(C)C1=O)c1c([nH]c3ccccc13)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 5/20 0.45
HAVCR2 Q8TDQ0 1/20 0.45
TOP2A P11388 2/20 0.41
CDK4 P11802 1/20 0.41
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41
CCND1 P24385 1/20 0.41
MYLK Q15746 1/20 0.40
XDH P47989 2/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
BRD4 O60885 1/20 0.37
HTR6 P50406 2/20 0.36
CHRM2 P08172 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2A P08913 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6864479 0.90 MPO (0.45) MPOHAVCR2TOP2ACDK4PRKACA
SCHEMBL6860285 0.90 PRKACA (0.47) MPOHAVCR2TOP2ACDK4PRKACA
SCHEMBL6866883 0.85 MPO (0.38) MPOHAVCR2TOP2ACDK4PRKACA
SCHEMBL6997570 0.78 SIRT2 (0.49) HAVCR2ALDH1A1KMT2ADRD2DRD4
SCHEMBL25333651 0.67 MPO (0.82) MPOHAVCR2XDHALDH1A1KMT2A
SCHEMBL4419395 0.67 MEN1 (0.63) MPOHAVCR2ALDH1A1KMT2AMAPT
SCHEMBL11736951 0.66 CDK4 (0.58) MPOHAVCR2TOP2ACDK4PRKACA
SCHEMBL11735517 0.66 CDK4 (0.58) MPOHAVCR2TOP2ACDK4PRKACA
Hydrochloric Acid SCHEMBL9725349 0.66 RAB9A (0.64) MPOHAVCR2ALDH1A1KMT2AMAPT
SCHEMBL7198661 0.65 GSK3B (0.58) HAVCR2ALDH1A1KMT2AHTR6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109785-B1 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ZENTARIS AG (DE) 2003-01-02 EP disclosed